Medicare mandates to reduce chemical restraints
On Wednesday, Medicare announced an initiative to reduce the use of antipsychotics drugs among dementia patients by 15 percent by the end of the year, using techniques like the one above. Federal officials said such drugs are dangerous for elderly patients with dementia—nearly doubling the risk of death —and are overused as a way to control difficult behaviors of nursing home patients. In fact, every two in five nursing home patients with dementia is given antipsychotics even though they have no diagnosed psychosis, said Dr. Sherry Ling, deputy chief of the Center for Medicare and Medicaid Services, during a telephone news conference on Wednesday.
- Governors Push to Expand Role of PAs, Telemedicine
- 3 More Pioneer ACOs Say They Will Quit
- Why Open Payments Irks Physicians
- Telemetry Overuse Cost Health System $4.8 Million in One Year
- Ebola in the U.S.: Reason to Fear, to Hope, to Prepare
- Top Provider Billing Mistakes Are Changing
- Overcoming a Payer Mix 'Nightmare'
- Employee Engagement: Make It Meaningful
- Difficult Patients: It's Not Them, It's You, Doctor
- IV Fluids Shortage Continues